We would like to announce a clinical trial study for high risk naïve, relapsed or refractory Myelodysplastic Syndrome (MDS) patients. + Read More

Would you like your treatment center to become part of the referral system for MDS patients and be designated as a Center of Excellence? To be recognized as a Center of Excellence, an institution must have:+ Read More

MDS EDUCATIONAL RESOURCES ORDER FORM

European Oncology & Haematology enables time-pressured physicians to stay abreast of key advances and opinion in oncological and haematological practice in Europe.+ Read More

Developed by the International Working Group for the Prognosis of MDS (IWG-PM) under the aegis of the MDS Foundation, Inc.+ Read More